Immune Design Corp.
IMDZ
IMDZ was delisted on the 1st of April, 2019.
68 hedge funds and large institutions have $165M invested in Immune Design Corp. in 2019 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 23 closing their positions.
838% more call options, than puts
Call options by funds: $75K | Put options by funds: $8K
324% more capital invested
Capital invested by funds: $39M → $165M (+$126M)
17% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 23
6% more funds holding
Funds holding: 64 → 68 (+4)
3.91% less ownership
Funds ownership: 62.34% → 58.43% (-3.9%)
22% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 18
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$8.18M |
| 2 |
TAL
TIG Advisors LLC
New York
|
+$6.87M |
| 3 |
GF
Gabelli Funds
Rye,
New York
|
+$4.47M |
| 4 |
SAM
Sandell Asset Management
New York
|
+$4.43M |
| 5 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
+$3.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$7.28M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$6.74M |
| 3 |
VVM
Versant Venture Management
San Francisco,
California
|
-$2.87M |
| 4 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
-$1.16M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$879K |
IMDZ Hedge Fund Activity: Q1 2019 in Review
68 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q1 2019, worth a combined $165M — up 324% from $39M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new IMDZ positions and 23 closed out — a net gain of 4 holders — while 14 added to existing stakes and 18 trimmed.
The largest buyer was Alpine Associates Management, opening a new position worth an estimated $8.18M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $7.28M sold.
- 68 institutional investors held Immune Design Corp. (IMDZ) as of Q1 2019, up from 64 in Q4 2018.
- Funds reported $165M of Immune Design Corp. stock for Q1 2019, up 324% quarter-over-quarter.
- 27 funds opened new Immune Design Corp. positions in Q1 2019 and 23 closed out, a net change of +4 holders.
- The largest Immune Design Corp. buyer in Q1 2019 was Alpine Associates Management, an estimated $8.18M added.
- The largest Immune Design Corp. seller in Q1 2019 was EcoR1 Capital, an estimated $7.28M sold.
Based on aggregated 13F filings for Q1 2019.